These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 230927)

  • 21. Effect of prednisone dose spacing on plasma lipids.
    Galla JH; Curtis JJ; Woodford SY; Rees ED; Somes GW; Luke RG
    J Lab Clin Med; 1980 Jun; 95(6):801-7. PubMed ID: 6991620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
    Seplowitz AH; Smith FR; Berns L; Eder HA; Goodman DS
    Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.
    Bagdade J; Casaretto A; Albers J
    J Lab Clin Med; 1976 Jan; 87(1):38-48. PubMed ID: 173766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
    Crouse JR; Grundy SM
    Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clofibrate decreases jejunal cholesterol synthesis and activity of postheparin plasma lipoprotein lipase in the rat.
    Strandberg TE; Kuusi T; Tilvis RS; Miettinen TA
    Pharmacology; 1983; 26(5):290-6. PubMed ID: 6856670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined hyperlipidemia and hypertriglyceridemia in renal allograft recipients. Comparison with non-renal combined hyperlipidemic or hypertriglyceridemic patients and normal subjects.
    Somer JB; Abbott LK; Aitken JM; Elliott C
    Clin Chim Acta; 1979 Oct; 97(2-3):123-34. PubMed ID: 226288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats.
    Ohata I; Sakamoto N; Nagano K; Maeno H
    Biochem Pharmacol; 1984 Jul; 33(14):2199-205. PubMed ID: 6466343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of polyenyl phosphatidyl choline on clofibrate-induced increase in LDL cholesterol.
    Schneider J; Müller R; Buberl W; Kaffarnik H; Schubotz R; Hausmann L; Mühlfellner G; Mühlfellner O
    Eur J Clin Pharmacol; 1979 Feb; 15(1):15-9. PubMed ID: 217694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypercholesterolemia in renal allograft recipients. Comparison with non-renal hypercholesterolemia and normal subjects.
    Somer JB; Abbott LK; Elliott C; Aitken JM
    Atherosclerosis; 1978 Aug; 30(4):255-62. PubMed ID: 213082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of renal transplantation on hyperlipidemia and high-density lipoprotein cholesterol (HDL).
    Curtis JJ; Galla JH; Woodford SY; Rees ED; Luke RG
    Transplantation; 1978 Nov; 26(5):364-6. PubMed ID: 212852
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma protein concentrations in hypertriglyceridaemic subjects. Effect of clofibrate and comparison with normal subjects.
    Ballantyne FC; Morrison BA; Ballantyne D; Dryburgh FJ; Epenetos AA
    Clin Chim Acta; 1978 Jul; 87(1):43-7. PubMed ID: 668144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patients.
    Dujovne CA; Azarnoff DL; Pentikainen P; Manion CV; Hurwitz A
    Am J Med Sci; 1979; 277(3):255-61. PubMed ID: 222145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein lipids in renal transplant recipients of different pre-transplant etiology of renal disease. A comparison of male and female patients.
    Somer JB; Aitken JM; Abbott LK; Charlesworth JA; Macdonald GJ
    Atherosclerosis; 1981 May; 39(2):177-82. PubMed ID: 7018503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of vitamin E on serum cholesterol and triglycerides in hyperlipidemic patients treated with diet and clofibrate.
    Leonhardt ET
    Am J Clin Nutr; 1978 Jan; 31(1):100-5. PubMed ID: 202160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of clofibrate and a fat-modified diet on serum lipids.
    Brown HB; Lewis LA; Page IH
    Clin Pharmacol Ther; 1975 Feb; 17(2):171-8. PubMed ID: 164312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of etofibrate on low density lipoprotein metabolism.
    Series JJ; Caslake MJ; Kilday C; Cruickshank A; Demant T; Packard CJ; Shepherd J
    Atherosclerosis; 1988 Feb; 69(2-3):233-9. PubMed ID: 3348843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clofibrate raises plasma apoprotein A-I and HDL-cholesterol concentrations.
    Nestel PJ; Hunt D; Wahlqvist ML
    Atherosclerosis; 1980 Dec; 37(4):625-9. PubMed ID: 7459005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of pre-transplant etiology of renal disease on lipoprotein lipids in female renal allograft receipients.
    Somer JB; Aitken JM; Abbott LK; Macdonald GJ; Charlesworth JA
    Atherosclerosis; 1980 Sep; 37(1):1-9. PubMed ID: 7000088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chitosan on plasma lipids and lipoproteins: a 4-month prospective pilot study.
    Rizzo M; Giglio RV; Nikolic D; Patti AM; Campanella C; Cocchi M; Katsiki N; Montalto G
    Angiology; 2014 Jul; 65(6):538-42. PubMed ID: 23785043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High density and low density lipoproteins in chronic renal failure before and after renal transplantation.
    Gibson JC; Savdie E; Simons LA; Stewart JH; Mahony JF
    Aust N Z J Med; 1979 Apr; 9(2):136-42. PubMed ID: 222252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.